pentostatin [Pentostatin]

tematický
11
Termíny

2'-deoxykoformycin
deoxykoformycin
Nipent

 

2'-Deoxycoformycin
CI-825
Co-Vidarabine
Deoxycoformycin
Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-
Nipent
NSC-218321

Perzistentní odkaz   https://www.medvik.cz/link/D015649
Definice

Silný inhibitor adenosindeaminázy. Lék vyvolává apoptózu lymfocytů a používá se k léčbě mnoha lymfoproliferativních malignit, zejména vlasatobuněčné leukemie. Je také synergický s některými dalšími protinádorovými látkami a má imunosupresivní aktivitu.

A potent inhibitor of ADENOSINE DEAMINASE. The drug induces APOPTOSIS of LYMPHOCYTES, and is used in the treatment of many lymphoproliferative malignancies, particularly HAIRY CELL LEUKEMIA. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.

DUI
D015649 MeSH Prohlížeč
CUI
M0023987
CAS
Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-
Předchozí užití
Azepines (1966-1978); Coformycin/analogs & derivatives (1979-1989); Deoxyribonucleosides (1971-1978)
Historická pozn.
1997 (1990); for CO-VIDARABINE use PENTOSTATIN 1982-1997
Veřejná pozn.
1997; CO-VIDARABINE (now PENTOSTATIN) was indexed under VIDARABINE/*analogs & derivatives 1976-97

D Chemikálie a léčiva
D03.383.742 pyrimidiny 959
D03.383.742.680 pyrimidinové nukleosidy 23
D03.383.742.680.350 formyciny 2
D03.383.742.680.350.200 koformycin 1
D03.383.742.680.350.200.700 pentostatin 11
D13.570 nukleosidy 265
D13.570.230 deoxyribonukleosidy 14
D13.570.230.229 deoxyadenosiny 14
D13.570.230.329 deoxycytidin 307
D13.570.230.360 deoxyguanosin 45
D13.570.230.430 deoxyuridin 15
D13.570.230.500 dideoxynukleosidy 19
D13.570.230.677 pentostatin 11
D13.570.230.855 thymidin 194
D13.570.685.350 formyciny 2
D13.570.685.350.200 koformycin 1
D13.570.685.350.200.700 pentostatin 11